Chang Chi-Jen, Liu Shih-Chi, Tsai Cheng-Ting, Cheng Jen-Fang, Lee Chien-Lin, Lin Chia-Pin, Huang Chi-Hung, Liou Jun-Ting, Wang Yi-Chih, Hwang Juey-Jen
Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Cardiovascular Division, Department of Internal Medicine, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.
Front Cardiovasc Med. 2022 Mar 1;9:769073. doi: 10.3389/fcvm.2022.769073. eCollection 2022.
Lesion characteristics were shown to predict procedural success and outcomes in chronic total occlusion (CTO) recanalization. However, diverse techniques involved in these studies might cause potential heterogeneity.
The study aimed to test the impacts of lesion characteristics on CTO intervention with a pure antegrade wiring-based technique.
We studied consecutive 325 patients (64.5 ± 11.1 years, 285 men) with native CTO lesions intervened by a single operator with an antegrade-based technique between August 2014 and July 2020. Forty-seven patients with antegrade procedural failure (20 with pure antegrade wiring failure and 27 with back-up retrograde techniques) were compared to 278 patients with antegrade-only procedural success. With a median follow-up of 30.8 (16.1-48.6) months, 278 patients with procedural success were further assessed for target vessel failure (TVF: cardiac death, target vessel myocardial infarction [MI], and target lesion revascularization [TLR]). Patients with antegrade procedural success had a lower percentage of history with bypass graft (4 vs. 15%, = 0.004) and lower Multicenter Chronic Total Occlusion Registry of Japan (J-CTO) score (2.1±1.3 vs. 3.4 ± 1.0, < 0.001), when compared to those with antegrade failure. The J-CTO score was independently associated with procedural failure (odds ratio = 2.5, 95% CI = 1.8-3.4) in multivariate analysis. However, only clinical features, such as female gender (hazard ratio [HR] = 4.3, 95% CI = 1.4-13.1), estimated glomerular filtration rate <60 ml/min/1.73 m (HR = 3.2, 95% CI = 1.0-9.9), and old MI (HR = 4.5, 95% CI = 1.5-12.8), but not J-CTO score, could predict long-term TVF in multivariate Cox regression model.
The feasibility of the antegrade guidewire-crossing technique for native CTO intervention was highly determined by lesion characteristics. With such a simpler technique, the prognostic impact of lesion complexity shown in studies with multiple recanalization techniques was negligible. This suggested antegrade true lumen tracking techniques deserved to be tried better even for CTO lesions with higher complexity.
病变特征已被证明可预测慢性完全闭塞(CTO)再通的手术成功率和预后。然而,这些研究中涉及的多种技术可能会导致潜在的异质性。
本研究旨在测试基于单纯正向导丝技术的病变特征对CTO介入治疗的影响。
我们研究了2014年8月至2020年7月期间由一名操作者采用基于正向导丝技术介入治疗的325例连续性原发性CTO病变患者(64.5±11.1岁,285例男性)。将47例正向手术失败的患者(20例单纯正向导丝失败,27例采用备用逆向技术)与278例仅正向手术成功的患者进行比较。中位随访时间为30.8(16.1 - 48.6)个月,对278例手术成功的患者进一步评估靶血管失败(TVF:心源性死亡、靶血管心肌梗死[MI]和靶病变血运重建[TLR])。与正向手术失败的患者相比,正向手术成功的患者既往有旁路移植史的比例较低(4%对15%,P = 0.004),日本多中心慢性完全闭塞注册研究(J - CTO)评分较低(2.1±1.3对3.4±1.0,P < 0.001)。在多变量分析中,J - CTO评分与手术失败独立相关(比值比 = 2.5,95%可信区间 = 1.8 - 3.4)。然而,在多变量Cox回归模型中,只有临床特征,如女性(风险比[HR] = 4.3,95%可信区间 = 1.4 - 13.1)、估计肾小球滤过率<60 ml/min/1.73 m²(HR = 3.2,95%可信区间 = 1.0 - 9.9)和陈旧性MI(HR = 4.5,95%可信区间 = 1.5 - 12.8),而不是J - CTO评分,能够预测长期TVF。
原发性CTO介入治疗中正向导丝通过技术的可行性高度取决于病变特征。采用这种更简单的技术,在多种再通技术的研究中显示的病变复杂性对预后的影响可忽略不计。这表明即使对于复杂性较高的CTO病变,正向真腔追踪技术也值得更好地尝试。